QIP completed - 2.11 cr shares allotted at Rs 354 each, raising Rs 750 cr
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gujarat Themis Biosyn allotted 2,11,86,440 equity shares at Rs 354 each through a QIP, raising about Rs 750 crore. The issue was priced at a 4.98 percent discount to the floor price. Paid-up equity capital rose from Rs 10.90 crore to Rs 13.01 crore. Top allottees include Quant Mutual Fund schemes (around 40 percent combined), Kotak Mahindra Life Insurance at 13.33 percent, and Ayushmat Ltd at 11.33 percent.
Equity base expanded by 19.4 percent to 13.01 crore shares. Rs 750 cr raised points to growth or capex plans, but near-term EPS dilution is expected from new shares.